Trevi Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.3%.

Top 25 shareholders own 76.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.1%	New Enterprise Associates, Inc.	11,370,376	US$36.0m	0%	2.02%
10.5%	Frazier Life Sciences Management, LP	7,381,090	US$23.4m	0%	0.96%
7.9%	Rubric Capital Management LP	5,564,123	US$17.6m	-2.12%	0.31%
6.25%	Viking Global Investors LP	4,400,000	US$13.9m	0%	0.05%
4.86%	VR Adviser, LLC	3,422,675	US$10.8m	0.01%	0.43%
4.47%	Armistice Capital LLC	3,147,200	US$10.0m	0%	0.26%
3.76%	Opaleye Management Inc.	2,645,000	US$8.4m	4.34%	1.67%
3.37%	BlackRock, Inc.	2,375,709	US$7.5m	2.41%	no data
3.27%	The Vanguard Group, Inc.	2,303,648	US$7.3m	2.69%	no data
3.12%	Logos Global Management, L.P.	2,200,000	US$7.0m	0%	0.74%
1.98%	Rosalind Advisors, Inc.	1,391,577	US$4.4m	50.3%	2.74%
1.9%	BioImpact Capital LLC	1,340,960	US$4.3m	0%	0.62%
1.61%	MAI Capital Management, LLC	1,131,821	US$3.6m	-11.5%	0.03%
1.27%	Geode Capital Management, LLC	897,965	US$2.8m	5.66%	no data
1.2%	Silverarc Capital Management, LLC	844,235	US$2.7m	-2.27%	0.7%
1.13%	State Street Global Advisors, Inc.	798,249	US$2.5m	7.7%	no data
1.05%	Landscape Capital Management, LLC	740,128	US$2.3m	-18.7%	0.2%
0.72%	Checkpoint Capital, LLC, Asset Management Arm	506,082	US$1.6m	-60.8%	0.96%
0.5%	David Meeker	352,489	US$1.1m	0%	no data
0.47%	Northern Trust Global Investments	327,692	US$1.0m	4.3%	no data
0.3%	Thomas Sciascia	214,433	US$679.8k	4.78%	no data
0.3%	Jennifer Good	213,313	US$676.2k	0.9%	no data
0.28%	Simplify Asset Management Inc.	200,000	US$634.0k	0%	0.05%
0.2%	J. Goldman & Co., L.P.	137,873	US$437.0k	0%	0.02%
0.18%	BNY Asset Management	128,627	US$407.8k	-3.56%	no data